CHEN Zhigang's experience in treating multiple sclerosis based on the theory of "brain marrow-brain Qi-brain collaterals"

TIAN Hao; WANG Yao; REN Gengqing; JIA Chengru; ZHANG Han; ZHANG Kaige; LIU Xiaoxu; CHEN Zhigang

doi:10.16025/j.1674-1307.2024.12.014

您当前的位置：

首页 >

文章列表页 >

CHEN Zhigang's experience in treating multiple sclerosis based on the theory of "brain marrow-brain Qi-brain collaterals"

更新时间：2025-01-08

- CHEN Zhigang's experience in treating multiple sclerosis based on the theory of "brain marrow-brain Qi-brain collaterals"
- Beijing Journal of Traditional Chinese Medicine Vol. 43, Issue 12, Pages: 1401-1405(2024)
- 作者机构：
  
  1.北京中医药大学第二临床医学院，北京 100071
  2.北京中医药大学东方医院脑病一科，北京 100071
- 作者简介：
- 基金信息：
- DOI：10.16025/j.1674-1307.2024.12.014
  CLC：
- Published：25 December 2024，
  
  Received：07 March 2024，
- 稿件说明：
移动端阅览
田浩，王垚，任耕庆，等.陈志刚基于“脑髓-脑气-脑络”病机体系论治多发性硬化经验［J］.北京中医药，2024，43（12）：1401-1405.

TIAN Hao,WANG Yao,REN Gengqing,et al.CHEN Zhigang's experience in treating multiple sclerosis based on the theory of "brain marrow-brain Qi-brain collaterals"[J]. Beijing Journal of Traditional Chinese Medicine,2024,43(12):1401-1405.
田浩，王垚，任耕庆，等.陈志刚基于“脑髓-脑气-脑络”病机体系论治多发性硬化经验［J］.北京中医药，2024，43（12）：1401-1405. DOI： 10.16025/j.1674-1307.2024.12.014.

TIAN Hao,WANG Yao,REN Gengqing,et al.CHEN Zhigang's experience in treating multiple sclerosis based on the theory of "brain marrow-brain Qi-brain collaterals"[J]. Beijing Journal of Traditional Chinese Medicine,2024,43(12):1401-1405. DOI： 10.16025/j.1674-1307.2024.12.014.

摘要

陈志刚教授提出“脑髓-脑气-脑络”病机体系，认为脑髓属阴，在内为脑物质之源，脑气属阳，在外为脑功能之基，脑络传导气血，为沟通二者的关键通道，三者互相依存与制约，共同构成了一个整体的体系。陈教授从脑髓、脑气和脑络的角度阐释了MS的病机，指出脑气亏虚是MS的发病基础，脑气不足，虚邪上扰，风痰瘀火诸邪伏于脑络，蓄久不去，蕴毒伤髓，最终演变成伏毒积损为标，肾虚髓减为本的疾病状态；治疗上以补气、解毒、益髓为主，主张分期论治，早期病起于脑气不足，故以补气为重，兼顾祛邪，方用黄芪赤风汤加减，中后期以髓减为本，毒损为标，故以补肾益髓、解毒通络为主，标本兼治，方用地黄饮子加减。

Abstract

关键词

多发性硬化脑髓脑气脑络

Keywords

references

KURTZKE JF. MS epidemiology world wide. One view of current status[J]. Acta Neurol Scand Suppl,1995,161:23-33.

LI M, ZHOU N, DUAN S, et al. Burden and trends of multiple sclerosis in China from 1990 to 2019: a systematic analysis for the Global Burden of Disease Study 2019[J]. BMJ open,2022,12(12):e066335.

DOBSON R, GIOVANNONI G. Multiple sclerosis - a review[J]. Eur J Neurol, 2019,26(1):27-40.

邱伟，徐雁.多发性硬化诊断和治疗中国专家共识(2018版)[J].中国神经免疫学和神经病学杂志,2018,25(6):387-394.

薛静，陈志刚，李楠楠，等.从脑髓-脑神-脑气角度分期辨治阿尔茨海默病[J].中医杂志,2021,62(19):1684-1689.

韩自献.中医脑气学说与中医脑气平衡法导论[J].中国中医药现代远程教育,2008(5):398-399.

吴以岭.中医络病学说与三维立体网络系统[J].中医杂志,2003(6):407-409.

李澎，张占军，王永炎.论脑气络含义及在老年认知障碍疾病中的作用[J].中国中医基础医学杂志,2016,22(3):316-319.

刘晓艳，孙怡.补肾固髓片治疗多发性硬化的临床与实验研究[J].中国中西医结合杂志,2001(1):10-14.

代悦蔓，王立新.王立新教授以“伏邪”理论治疗中枢神经系统脱髓鞘疾病缓解期经验[J].中国医药导报,2018,15(33):126-129.

胡学强，麦卫华，王敦敬.多发性硬化413例患者的临床表现特点[J].中华神经科杂志,2004(1):11-14.

陆韵薇，于顾然.以周仲瑛“伏毒”学说论治视神经脊髓炎谱系病[J].中医杂志,2020,61(11):957-960.

LANZ TV, BREWER RC, HO PP, et al. Clonally expanded B cells in multiple sclerosis bind EBV EBNA1 and GlialCAM[J]. Nature,2022,603(7900):321-327.

LUCCHINETTI C, BRÜCK W, PARISI J, et al. A quantitative analysis of oligodendrocytes in multiple sclerosis lesions. A study of 113 cases[J]. Brain,1999,122 ( Pt 12):2279-2295.

黄海连，刘源.年龄相关性脑白质改变研究进展[J].汕头大学医学院学报,2011,24(2):118-120.

樊永平.多发性硬化中医病因病机和治疗[J].环球中医药,2013,6(9):668-670.

武继涛.郑绍周教授肾虚毒邪理论治疗多发性硬化学术思想浅析[J].中国中医药现代远程教育,2011,9(9):14-15.

刘晓楠，王冰，钱前进.马云枝教授中西医结合治疗多发性硬化验案1则[J].光明中医,2018,33(9):1245-1247.

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Diagnosis and treatment plan of integrated Chinese and western medicine for multiple sclerosis

TCM pathogenesis in the different stages of stroke based on the theory of “Xuanfu- brain collateral- toxin evil”

Understanding of pathogenesis and treatment by stages of multiple sclerosis in traditional Chinese Medicine

Related Author

FAN Yong-ping

TONG Yan-ping

YANG Tao

Fan Huan-huan

CAO Ke-gang

Ying GAO

Yao XIE

Jia LIU

Related Institution

首都医科大学附属北京天坛医院中医科

北京中医医院顺义医院针灸科

北京中医药大学中医脑病研究院

北京中医药大学东直门医院脑病科

湖南省中医药研究院附属医院脑病科

⁰